These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comprehensive chemical modification interference and nucleotide substitution analysis of an RNA pseudoknot inhibitor to HIV-1 reverse transcriptase. Green L; Waugh S; Binkley JP; Hostomska Z; Hostomsky Z; Tuerk C J Mol Biol; 1995 Mar; 247(1):60-8. PubMed ID: 7534830 [TBL] [Abstract][Full Text] [Related]
6. Selection of high-affinity RNA ligands to reverse transcriptase: inhibition of cDNA synthesis and RNase H activity. Chen H; Gold L Biochemistry; 1994 Jul; 33(29):8746-56. PubMed ID: 7518691 [TBL] [Abstract][Full Text] [Related]
7. In vitro evolution of functional nucleic acids: high-affinity RNA ligands of HIV-1 proteins. Tuerk C; MacDougal-Waugh S Gene; 1993 Dec; 137(1):33-9. PubMed ID: 7506690 [TBL] [Abstract][Full Text] [Related]
8. Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers. Held DM; Kissel JD; Thacker SJ; Michalowski D; Saran D; Ji J; Hardy RW; Rossi JJ; Burke DH J Virol; 2007 May; 81(10):5375-84. PubMed ID: 17329328 [TBL] [Abstract][Full Text] [Related]
9. Anti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptase. Moore PS; Jones CJ; Mahmood N; Evans IG; Goff M; Cooper R; Hay AJ Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):129-34. PubMed ID: 7536411 [TBL] [Abstract][Full Text] [Related]
10. Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells. Bordier B; Perala-Heape M; Degols G; Lebleu B; Litvak S; Sarih-Cottin L; Hélène C Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9383-7. PubMed ID: 7568137 [TBL] [Abstract][Full Text] [Related]
11. High-throughput sequence analysis reveals structural diversity and improved potency among RNA inhibitors of HIV reverse transcriptase. Ditzler MA; Lange MJ; Bose D; Bottoms CA; Virkler KF; Sawyer AW; Whatley AS; Spollen W; Givan SA; Burke DH Nucleic Acids Res; 2013 Feb; 41(3):1873-84. PubMed ID: 23241386 [TBL] [Abstract][Full Text] [Related]
12. HIV-1 reverse transcriptase-pseudoknot RNA aptamer interaction has a binding affinity in the low picomolar range coupled with high specificity. Kensch O; Connolly BA; Steinhoff HJ; McGregor A; Goody RS; Restle T J Biol Chem; 2000 Jun; 275(24):18271-8. PubMed ID: 10751399 [TBL] [Abstract][Full Text] [Related]
13. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques. Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466 [TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. Richman D; Shih CK; Lowy I; Rose J; Prodanovich P; Goff S; Griffin J Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11241-5. PubMed ID: 1722324 [TBL] [Abstract][Full Text] [Related]
15. Identifying consensus patterns and secondary structure in SELEX sequence sets. Davis JP; Janjić N; Javornik BE; Zichi DA Methods Enzymol; 1996; 267():302-14. PubMed ID: 8743324 [No Abstract] [Full Text] [Related]
16. The structure of HIV-1 reverse transcriptase complexed with an RNA pseudoknot inhibitor. Jaeger J; Restle T; Steitz TA EMBO J; 1998 Aug; 17(15):4535-42. PubMed ID: 9687519 [TBL] [Abstract][Full Text] [Related]
17. A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150). Mellors JW; Im GJ; Tramontano E; Winkler SR; Medina DJ; Dutschman GE; Bazmi HZ; Piras G; Gonzalez CJ; Cheng YC Mol Pharmacol; 1993 Jan; 43(1):11-6. PubMed ID: 7678690 [TBL] [Abstract][Full Text] [Related]
18. Phosphorodithioate DNA as a potential therapeutic drug. Marshall WS; Caruthers MH Science; 1993 Mar; 259(5101):1564-70. PubMed ID: 7681216 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine. Marshall WS; Beaton G; Stein CA; Matsukura M; Caruthers MH Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6265-9. PubMed ID: 1378623 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors. Cushman M; Golebiewski WM; Graham L; Turpin JA; Rice WG; Fliakas-Boltz V; Buckheit RW J Med Chem; 1996 Aug; 39(16):3217-27. PubMed ID: 8759644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]